Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma's Board of Directors

LOS ANGELES, April 24, 2018 -- (Healthcare Sales & Marketing Network) -- GT Biopharma Inc. (OTCQB: GTBP and Euronext Paris "GTBP.PA") today announced that Dr. Peter Kiener will join GT Biopharma's Board of Directors, effective immediately. Dr... Biopharmaceuticals, Oncology, Personnel GT Biopharma, Natural Killer Cell Engagers, lymphoma, leukemia
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news